Högenauer G
Wien Klin Wochenschr. 1979 Mar 30;91(7):211-8 7-b.
The prevalence of resistance factors (R-factors) has become a serious threat to the chemotherapeutic armament of modern medicine. These extrachromosomal elements exert their effects by supplying the harbouring bacterial cell with the genetic information for detoxifying enzymes, for the expression of biochemical mechanisms which effectively prevent antibiotic molecules from reaching their target or for the synthesis of resistant target molecules. The genes which are responsible for these effects were recently shown to reside on "transposons", genetic entities which can recombine with various DNA moieties, like plasmids, bacterial chromosomes, or the genome of bacteriophages. The transposon nature of most resistance determinants provide the bacterial world with an enormous flexibility in the response to antibiotic selection pressure. It is an absolute requirement for the future to stop further spread of R-factors by reducing the selection pressure. Doctors will have to apply antibiotics more selectively, and in animal breeding and growth promotion only those drugs should be used which are never prescribed for humans. Moreover, pharmaceutical research should be directed towards the development of compounds acting on R-factors or on their enzyme systems.
耐药因子(R因子)的流行已成为现代医学化疗手段的严重威胁。这些染色体外元件通过为宿主细菌细胞提供解毒酶的遗传信息、有效阻止抗生素分子到达其靶点的生化机制的表达信息或抗性靶点分子的合成信息来发挥作用。最近发现,负责这些作用的基因存在于“转座子”上,转座子是一种可以与各种DNA部分(如质粒、细菌染色体或噬菌体基因组)重组的遗传实体。大多数耐药决定因素的转座子性质使细菌界在应对抗生素选择压力时具有极大的灵活性。通过降低选择压力来阻止R因子的进一步传播是未来的绝对必要条件。医生必须更有选择性地使用抗生素,在动物育种和生长促进中,只应使用那些从不给人类开的药物。此外,药物研究应致力于开发作用于R因子或其酶系统的化合物。